Nuo Therapeutics, Inc. (AURX)
enVVeno Medical Corp (NVNO)
enVVeno Medical Participates in a New Virtual Investor “What This Means” Segment to Discuss How President Trump’s Recent CVI Diagnosis May Impact the Company
enVVeno Medical Corp (NVNO)
enVVeno Medical Participates in a New Virtual Investor "What This Means" Segment to Discuss How President Trumps Recent CVI Diagnosis May Impact the Company
Nuo Therapeutics, Inc. (AURX)
Cumberland Pharmaceuticals Inc. (CPIX)
CUMBERLAND PHARMACEUTICALS RECEIVES VIZIENT CONTRACT FOR NEWVIBATIV® 4-VIAL STARTER PAK
Clearbridge Health Limited (1H3)
Pacific Biosciences of California Inc (PACB)
Nature Methods Paper Leverages PacBio Sequencing Technology to Develop the Platinum Pedigree Benchmark, a New Standard for Accurate Characterization of Variation in the Human Genome that Improves Training for AI Models
Xtant Medical Holdings Inc. (XTNT)
New Form 8-K - Xtant Medical Holdings, Inc. Filed: 2025-08-04 AccNo: 0001641172-25-022002 Size: 216 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 9.01: Financial Statements and Exhibits
Mangoceuticals Inc (MGRX)
New Form 8-K - MANGOCEUTICALS, INC. Filed: 2025-08-04 AccNo: 0001493152-25-011557 Size: 277 KB Item 1.01: Entry into a Material Definitive Agreement Item 1.02: Termination of a Material Definitive Agreement Item 2.01: Completion of Acquisition or Disposition of Assets Item 3.02: Unregistered Sales of Equity Securities Item 9.01: Financial Statements and …
AIM ImmunoTech Inc. (AIM)
AIM ImmunoTech Builds Positive Momentum and Reiterates Focus on Driving Ampligen® Clinical Development Toward Pancreatic Cancer Approval
Anixa Biosciences Inc. (ANIX)
AIM ImmunoTech Inc. (AIM)
AIM ImmunoTech Builds Positive Momentum and Reiterates Focus on Driving Ampligen® Clinical Development Toward Pancreatic Cancer Approval
Westlake Chemical Corporation (WLK)
Westlake Royal Building Products™ Introduces Haint Blue Color for Royal® Reversible Beadboard/V-Groove Profile
enGene Inc (ENGNW)
enGene Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)